← FDA DRUG APPROVALS

FDA ANDA · ANDA208181

TIAGABINE HYDROCHLORIDE

Sponsor: AMNEAL PHARMS CO

APPLICATION
ANDA208181
TYPE
ANDA
ORIGINAL APPROVAL
2017-12-08
LATEST ACTION
2017-12-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TIAGABINE HYDROCHLORIDEDiscontinued
TIAGABINE HYDROCHLORIDE 16MG · TABLET · ORAL
TIAGABINE HYDROCHLORIDEDiscontinued
TIAGABINE HYDROCHLORIDE 4MG · TABLET · ORAL
TIAGABINE HYDROCHLORIDEDiscontinued
TIAGABINE HYDROCHLORIDE 12MG · TABLET · ORAL
TIAGABINE HYDROCHLORIDEDiscontinued
TIAGABINE HYDROCHLORIDE 2MG · TABLET · ORAL

Approval history

2017-12-08UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →